Related Experiment Video
Updated: Dec 21, 2025
08:16
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
Published on: July 7, 2017
7.8K
Lung Disease Diagnostic Model Through IgG Sensitization to Microbial Extracellular Vesicles
Jinho Yang1,2, Goohyeon Hong3, Youn Seup Kim3
1Institute of MD Healthcare Inc., Seoul, Korea.
Allergy, Asthma & Immunology Research
|May 14, 2020
Summary
Indoor dust bacterial extracellular vesicles (EVs) are linked to lung diseases. Detecting antibodies against these bacterial EVs in serum shows promise as a diagnostic tool for asthma, COPD, and lung cancer.
Area of Science:
- Environmental microbiology
- Immunology
- Pulmonary medicine
Background:
- Indoor dust composition is increasingly studied due to its association with lung diseases like asthma, COPD, and lung cancer.
- Bacterial extracellular vesicles (EVs) in dust can induce pulmonary inflammation, suggesting a role in lung disease pathogenesis.
Purpose of the Study:
- To analyze the microbiome of indoor dust EVs.
- To develop diagnostic models for lung disease using serum antibodies against bacterial EVs.
Main Methods:
- Microbiome analysis of bacterial EVs isolated from indoor dust (mattresses).
- Enzyme-linked immunosorbent assay (ELISA) to detect serum antibodies (IgG, IgG1, IgG4) against specific bacterial EVs.
- Development of logistic regression models to diagnose lung disease based on antibody levels.
Main Results:
- Proteobacteria was the dominant phylum; Pseudomonas, Enterobacteriaceae, and Acinetobacter were prominent genera.
- Significantly higher levels of anti-bacterial EV antibodies were found in patients with asthma, COPD, and lung cancer compared to controls.
- Diagnostic models achieved areas under the curve ranging from 0.72 to 0.81.
Conclusions:
- ELISA-based detection of anti-bacterial EV antibodies can serve as a diagnostic tool for lung disease.
- Findings offer insights into lung disease mechanisms and a basis for novel diagnostic methods combining microbial EV metagenomics and immune assays.
